Guidance for industry : adequate and appropriate donor screening for hepatitis b : hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes.

Guidance for industry : adequate and appropriate donor screening for hepatitis b : hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes.

Saved in:
Bibliographic Details
Imprint:Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2007]
Description:i, 4 pages : digital, PDF file
Language:English
Subject:
Blood donors.
Blood plasma -- Testing.
Leucocytes -- Testing.
Hepatitis associated antigen.
Hepatitis B -- United States -- Prevention.
Format: E-Resource U.S. Federal Government Document Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/7730966
Hidden Bibliographic Details
Varying Form of Title:Adequate and appropriate donor screening for hepatitis b
Hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes
Other authors / contributors:Center for Biologics Evaluation and Research (U.S.)
Notes:Title from PDF title page (viewed on May 5, 2009).
"November 2007".
Includes bibliographical references (page 4).
Mode of access: Internet at the FDA CBER web site. Address as of 5/4/09: http://www.fda.gov/cber/gdlns/hbslotrel.pdf ; current access is available via PURL.
GPO item no.:0499-T-02 (online)
Govt.docs classification:HE 20.4802:D 71

MARC

LEADER 00000cam a2200000Ia 4500
001 7730966
005 20090504143659.0
006 m d f
007 cr a||||||||||
008 090504s2007 mdu ob f000 0 eng d
003 ICU
035 |a (OCoLC)320121326 
040 |a GPO  |b eng  |c GPO  |d MvI 
074 |a 0499-T-02 (online) 
086 0 |a HE 20.4802:D 71 
245 0 0 |a Guidance for industry :  |b adequate and appropriate donor screening for hepatitis b : hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes. 
246 3 0 |a Adequate and appropriate donor screening for hepatitis b 
246 3 0 |a Hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes 
264 1 |a Rockville, MD :  |b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,  |c [2007] 
300 |a i, 4 pages :  |b digital, PDF file 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
538 |a Mode of access: Internet at the FDA CBER web site. Address as of 5/4/09: http://www.fda.gov/cber/gdlns/hbslotrel.pdf ; current access is available via PURL. 
500 |a Title from PDF title page (viewed on May 5, 2009). 
500 |a "November 2007". 
504 |a Includes bibliographical references (page 4). 
650 0 |a Blood donors.  |0 http://id.loc.gov/authorities/subjects/sh85014978 
650 0 |a Blood plasma  |x Testing. 
650 0 |a Leucocytes  |x Testing. 
650 0 |a Hepatitis associated antigen.  |0 http://id.loc.gov/authorities/subjects/sh85060294 
650 0 |a Hepatitis B  |z United States  |x Prevention. 
710 2 |a Center for Biologics Evaluation and Research (U.S.)  |0 http://id.loc.gov/authorities/names/n88098944  |1 http://viaf.org/viaf/125284200 
856 4 0 |u https://purl.fdlp.gov/GPO/LPS112191  |y Government Publishing Office 
903 |a HeVa 
903 |a HeVa 
929 |a eresource 
999 f f |i 7628d1b5-a17c-509a-b760-90af0ac5ea9f  |s 277e5538-493b-501f-bd9b-b741edebcbce 
928 |t Library of Congress classification  |l Online  |c UC-FullText  |u https://purl.fdlp.gov/GPO/LPS112191  |z Government Publishing Office  |g ebooks  |i 12813808 

Similar Items